An interventional study of Educational Video on Voiding Dysfunction in Dysfunctional Voiding, sponsored by University of Colorado, Denver. Not yet recruiting at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-07-25.
Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Treatment Adherence and Compliance with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Treatment Adherence and Compliance · United States.
Among the 75 studies in Treatment Adherence and Compliance with a site in United States, this one is the 26th largest by planned enrollment of the 70 interventional ones that give a count, is one of 2 that started in 2025, is one of 58 with no phase, reaches primary completion later than 6 of the 14 other live ones, and was the 68th registered.
353 studies on the registry are indexed under Treatment Adherence and Compliance; 108 are open to participants now.
Browse Treatment Adherence and Compliance studies →12 of the 75 studies in Treatment Adherence and Compliance with a site in United States are open now. Recruiting first, the newest first:
Virginia Commonwealth University · Sites in United States
Ages 18+
Northwestern University · Sites in United States
Healthy volunteers
University of Maryland, Baltimore · Sites in United States
Ages 18–65
The University of Texas Health Science Center at San Antonio · Sites in United States
Ages 18+ · Women only
National Heart, Lung, and Blood Institute (NHLBI) · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 59 Treatment Adherence and Compliance studies recruiting now, 46 (78%) set no upper age limit and 12 (20%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.
This study: 5 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 8 · Phase 3 4 · Phase 4 1
First in 2003; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 83 across 273 interventional studies indexed under Treatment Adherence and Compliance.
Median enrollment 66 across the 70 interventional studies, 384 across the 5 observational. Of the 57 that completed or were terminated, 23 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 75 have an industry lead sponsor. The 10 most frequent:
University of Colorado, Denver is the lead sponsor of 1,547 studies on the registry; 318 are open to participants now.
Of its 148 completed or terminated interventional studies of FDA-regulated products, 93 (63%) have results posted.
University of Colorado, Denver has 2 studies filed under Treatment Adherence and Compliance — fewer than ten, so there is no comparison to draw.
7 of the studies in Treatment Adherence and Compliance with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05489068University of New MexicoMotivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment | 2026-12-01 |
| NCT07542769Northwestern UniversityChoice and Autonomy in Learning Mindfulness for Pediatric Residents | 2026-12-31 |
| NCT07881783Novartis PharmaceuticalsA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy | 2027-03-31 |
| NCT05973838University of Maryland, College ParkPeer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention | 2027-07-01 |
| NCT06909552University of Colorado, DenverUse of an Educational Video to Improve Adherence to Treatment in Voiding Dysfunction | 2027-07-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 75 studies in Treatment Adherence and Compliance with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to see whether an educational video on a common urinary dysfunction leads to improved parent and child perceived adherence to treatments recommendations.
This study aims to explore whether the use of an educational video on voiding dysfunction, a common urinary dysfunction, leads to improve parents and child perceived adherence to behavioral treatment recommendations. Our main hypothesis explores whether there is improved perceived adherence, and whether this improved perceived adherence leads to better symptom outcomes in this condition.
We do so through randomizing patients to a control and intervention group, where the latter is exposed to the educational video, while the control group experiences standard of care visits/follow-ups. Data is collected through surveys pre and post exposure to the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will be exposed to a short 3-minute educational video following a visit with their urology provider.
Other: Educational Video on Voiding Dysfunction
Participants will not be exposed to an educational video; rather, they will receive standard of care education in clinic regarding behavioral treatment modalities at home.
The educational video is a short 3-minute video which describes the condition in detail, at the level that a parent or child could understand without a medical background.
Perceived Adherence
Participants will take the TAPQ perceived adherence assessment at time points 4 weeks and 8 weeks.
Time frame: 4 weeks, 8 weeks.
Video Acceptability
Immediately after watching the educational video, participants will be asked to complete a questionnaire on the acceptability of the video. this will occur at time frame 0 weeks (for intervention group).
Time frame: 0 weeks.
Dysfunctional Voiding Scoring System
Participants will be asked to complete a DVSS survey at timepoints 0 weeks, 4 weeks, and 8 weeks. This DVSS survey will be used to assess symptom improvement throughout the study.
Time frame: 0 weeks, 4 weeks, and 8 weeks.
Plan to share: No — resource limitations
Start is estimated for Aug 2025; primary completion for Jul 2027, 23 months later.
Of 180 non-industry interventional studies with no phase under Treatment Adherence and Compliance, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 36. This study's planned 23 months is above that.
Counting every sponsor, half of 185 studies reached it within 17 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Treatment Adherence and Compliance →
University of Colorado, Denver →